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ABSTRACT
Aims: The present study was undertaken to evaluate the effect of methanolic leaf extract of Gymnema sylvestre 
(MLGS) on glucose transport (GLUT) and insulin resistance in vitro. Materials and Methods: Peroxisome 
proliferator-activated receptor-gamma (PPAR-γ) and GLUT-4 expression were assessed in L6 myotubes for 
concluding the GLUT activity, and adiponectin and leptin expression was studied in 3T3 L1 murine adipocyte 
cell line to determine the effect of MLGS (250-750 μg/ml) on insulin resistance. Results: The findings of the 
experiments have demonstrated a significant and dose-dependent increase in glucose uptake in all the tested 
concentrations of MLGS, further the glucose uptake activity of MLGS (750 μg/ml) was at par with rosiglitazone 
(50 μg/ml). Concomitantly, MLGS has shown enhanced GLUT-4 and PPAR-γ gene expressions in L6 myotubes. 
Furthermore, cycloheximide (CHX) had completely abolished the glucose uptake activity of MLGS when co-
incubated, which further confirmed that glucose uptake activity of MLGS was linked to enhanced expression of 
GLUT-4 and PPAR-γ. In addition, in another experimental set, MLGS showed enhanced expression of adiponectin 
and leptin, thus confirms the ameliorative effect of MLGS on insulin resistance. Conclusion: These findings 
suggest that MLGS has an enhanced glucose uptake activity in L6 myotubes, and ameliorate the insulin 
resistance in 3T3 L1 murine adipocyte cell line in vitro.
KEY WORDS: Adiponectin, antidiabetic activity, diabetes, glucose transport, Gymnema sylvestre, leptin, L6 
myotubes, peroxisome proliferator-activated receptor-gamma, 3T3 L1 murine adipocyte cell line
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INTRODUCTION
Diabetes is a metabolic disorder of diverse etiology, manifested 
as hyperglycemia, polyuria, polydipsia, and polyphagia, 
characterized by disturbed carbohydrate, fat, and protein 
metabolism, due to defects in insulin secretion, and/or insulin 
action, or both [1]. Various classes of synthetic drugs are 
available for the treatment of diabetes; however, the inherent 
deleterious effects associated with these drugs have made 
a massive scope for discovering better and safe drug for 
the treatment of diabetes. In this perspective, plant-based 
medicines are believed to have great avenue over synthetic 
classes of drugs, and in recent times, many researchers have 
found numerous herbal medicines as highly promising in the 
treatment of diabetes [2]. In this context, Gymnema sylvestre is 
a very popular plant well known for its antidiabetic property, and 
it was scientifically validated for antidiabetic and hypoglycemic 
activity [3-6]. However, the molecular mechanism behind the 
hypoglycemic and antidiabetic activity of G. sylvestre remain 
uncertain, in this context we thought to evaluate the effect of 
G. sylvestre on glucose transporter-4 (GLUT-4), peroxisome 
proliferator-activated receptor-gamma (PPAR-γ), adiponectin, 
and leptin gene expression levels in vitro. GLUT-4 is one of the 
major GLUTs known to facilitate the glucose uptake in major 
tissues such as skeletal muscle, thus abnormal and/or decreased 
expression of GLUT-4 leads to diminished glucose uptake into 
the target tissues [7,8]. Further, PPAR-γ is a transcription factor 
belonging to the nuclear receptor superfamily, which is known 
to play a vital role in insulin signaling induced glucose uptake, 
and the role PPAR-γ in the development of insulin resistance 
has been scientifically well demonstrated, and therefore, the 
drugs that enhance PPAR-γ expression and/or acts as PPAR-γ 
agonists play a key role in reversing the insulin resistance [9-13].
In addition, adiponectin and leptin are the fundamental 
insulin-sensitizing adipokines secreted by adipocytes [14]. 
Adiponectin enhances insulin sensitivity and helps in controlling 
dyslipidemia through AMPK activation and increased fatty 
acid (FA) oxidation [15,16]. Scientifically, it is ascertained that 
abnormal and/or diminished expression of adiponectin leads to 
insulin resistance, dyslipidemia, and atherosclerosis in rodents 
and humans [17]. Similarly, leptin is an another adipocytokine 
produced by adipocytes, and it is known to play a remarkable 
role in controlling body weight, metabolism, and reproductive 
functions [18], Leptin presents in central nervous system acts 
as a checkpoint to control the food consumption, in short low 
levels of leptin leads to increased food consumption, and it 
is very clearly demonstrated in leptin knockout animals, and 
further leptin levels are observed to be significantly low in obese 
individuals compared to healthy volunteers [19,20]. Concisely, 
the available scientific literature suggests that GLUT-4, PPAR-γ, 
adiponectin, and leptin levels have a positive correlation in 
controlling the blood glucose levels and insulin resistance in 
patients suffering from diabetes and its complications.
Considering the potential anti-diabetic property of G. sylvestre, 
we thought to explore the possible correlation between the 
anti-diabetic activity of G. sylvestre and GLUT-4, PPAR-γ, 
adiponectin, and leptin gene expressions in vitro.
With the above hypothesis, the present study was designed to 
explore the possible mechanism behind the hypoglycemic and 
antidiabetic activity of G. sylvestre, through evaluating its effect on 
GLUT-4, PPAR-γ, adiponectin, and leptin gene expression in vitro.
MATERIALS AND METHODS
Reagents, Chemicals, and Cell Lines
Avian moloney leukemic virus (AMLV) reverse transcriptase 
(RT) and taq polymerase (dNTP) were purchased from Thermo 
Scientific, USA. Insulin, rosiglitazone, TRI reagent, cell culture 
supplements, and reagents used were of molecular biology grade 
and purchased from Sigma-Aldrich, St. Louis, USA.
Collection of Plant Material
The leaves of G. sylvestre were collected from Hospete (Bellary 
District, Karnataka, India) in the month of May-June 2013, 
considering the seasonal conditions for obtaining maximum 
phytoconstituents, and were authentified by Dr. K. P. Sreenath, 
Professor, Department of Botany, Bangalore University, 
Bengaluru, Karnataka, India. A voucher specimen of the 
plant material is preserved in the department with specimen 
no. 2013-14/GS/BT-01.
Plant Material Preparation
The shade dried leaf powder of G. sylvestre was subjected to 
extraction process as follows. Exactly 50 g of the plant material 
was extracted with various organic solvents successively in 
the ascending order of polarity (hexane, dichloromethane, 
ethylacetate, and methanol) in Soxhlet apparatus. In brief, 
50 g of the plant material was initially extracted with 1000 ml 
hexane at 60°C for 24 h, the marc obtained was completely 
dried and extracted with 1 L of dichloromethane for 24 h, and 
subsequently, the marc obtained was extracted with 1 L of ethyl 
acetate and followed by 1 L of methanol.
Extracts were concentrated by Rotary evaporator (Rotavap-Remi 
Instrument) under reduced pressure at room temperature, and 
4 mg of dried extract was reconstituted to 4 ml with respective 
solvents and diluted to attain the final concentration 750 μg/
ml, 500 μg/ml, and 250 μg/ml for glucose uptake studies.
Propagation and Maintenance of L6 Cells and 3T3 L1
L6 cells (Rat skeletal muscle), cell culture was procured from 
National Centre for Cell Sciences (NCCS), Pune, Maharashtra, 
India. L6 cells were cultured and maintained in Dulbecco’s 
modified Eagle’s medium (DMEM) with 10% inactivated 
fetal bovine serum (FBS) along with penicillin (100 μg/ml), 
streptomycin (100 μg/ml), and amphotericin B (5 μg/ml) in an 
humidified atmosphere of 5% CO2 at 37°C until confluent. The 
cells were dissociated with trypsin phosphate versene glucose 
solution (0.2% trypsin, 0.02% EDTA, and 0.05% glucose in 
phosphate buffered saline). The stock cultures were grown 
in 25 cm2 culture flasks, and the experiments were carried out 
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in 60 mm petri dishes and 96 well microtiter plates (Tarsons 
India Pvt., Ltd., Kolkata, West Bengal, India) [21].
3T3 L1 adipocyte cell culture was procured from NCCS, Pune, 
Maharashtra, India. The cells were grown to confluence in 
DMEM containing glucose. The monolayer of the 3T3 L1 cells 
was trypsinized and resuspended at 1 × 104 cells/ml in DMEM 
with 10% FBS. 0.5 ml of cell suspension was seeded per well in 
24 well plates (Tarsons India Pvt. Ltd., Kolkata, India); the plates 
were incubated and allowed to attain the confluent monolayer. 
Growth medium was removed and followed by the addition of 
adipogenesis initiation media containing 0.5 mm 3-iso butyl-
1-methyl xanthine, 10% FBS and 1 μm dexamethasone in 
DMEM. Initially, the cell lines were incubated for 48 h at 5% 
CO2 at 37°C, after incubation adipogenesis initiation media 
was replaced by adipogenesis progression media (DMEM with 
10% FBS and 10 μm/ml insulin). Subsequently, the plate was 
incubated for 48 h at 5% CO2 at 37°C, and then adipogenesis 
progression media was removed, and the cells were treated with 
various concentrations of test extracts along with controls in 
adipogenesis maintenance media (DMEM with 10% FBS). 
The test drugs samples were dissolved in DMEM media and 
incubated with adipogenesis maintenance media [22].
Glucose Uptake Assay
The fully differentiated L6 myotubes were serum starved 
overnight and washed with HEPES in KREB’s Ringer phosphate 
solution (KRP buffer) and incubated with KRP buffer with 0.1% 
bovine serum albumin for 30 min at 37°C. Myotubes were treated 
with various concentrations of test drug, and standard along 
with vehicle controls in 60 mm Petri plates, D-glucose solution 
was added to all the plates and incubated for 30 min at 37°C. 
Subsequently, the liquid medium was aspirated from all the 
plates to terminate the glucose uptake, and the cells were washed 
thrice with ice-cold KRP buffer solution. Further, the cells were 
lysed with 0.1 M NaOH solution and an aliquot of the cell lysates 
were used to measure the cell-associated glucose. Glucose uptake 
was estimated by Biovision Kit Inc., USA. Three independent 
experimental values in duplicates were taken to determine the 
percentage enhancement of glucose uptake over controls [23,24].
RT-Polymerase Chain Reaction (RT-PCR)
RT-PCR was carried out as per Kumar et al., 2015 [21,23]. 
In short, after the completion of the incubation period, 
the cells were lysed in TRI reagent, proteins were extracted 
with chloroform, and the total RNA was precipitated with 
isopropanol. The RNA precipitate was washed with 70% ethanol 
and resuspended in 50 μl of DEPC-treated water. Reverse 
transcription was carried out using 200 units of avian RT and 
200 ng/μl oligo d(T)18. The primers used were as follows, 
GLUT-4: Sense, 5’-CGG GAC GTG GAG CTG GCC GAG 
GAG-3’; anti-sense, 5’CCC CCT CAG CGA GTG A-3’ (318-
bp), [12]; PPAR-γ; sense, 5’-GGA TTC ATG ACC AGG GAG 
TTC CTC-3’; anti-sense, 5’-GCG GTC TCC ACT GAG AAT 
AAT GAC-3’ (155-bp), [12]; glyceraldehydes-3-phosphate 
dehydrogenase (GAPDH); sense, 5’CCA CCC ATG GCA AAT 
TCC ATG GCA-3’; anti-sense, 5’-TCT AGA CGG CAG GTC 
AGG TCC ACC-3’ (588-bp) [12]. For PCR reaction, 1 μl of 
cDNA mixture was added to a PCR reaction mix containing ×10 
PCR buffer, 2 mM dNTP, 10 pM of paired primers, 2 units of 
dNTP. PCR products were run on 1.5% agarose gels, stained 
with ethidium bromide and photographed.
Total RNA was obtained from cultured 3T3-L1 adipocytes 
(Day 8) as per previously mentioned procedures. cDNA was 
generated from total RNA and synthesized using a high capacity 
cDNA reverse transcription kit. The PCR conditions were as 
follows: For GAPDH, 25 cycles of 95°C for 30 s, 55° C for 30 s.
T h e  p r i m e r s  u s e d  a r e  a d i p o n e c t i n :  S e n s e , 
5 ’ - GT TCTACTGCAACAT TCCGG -3 ’ ;  an t i s ense , 
5 ’-TACACCTGGAGCCAGACTTG-3 ’; leptin: Sense, 
5 ’ -TGTGCTGCAGATAGCCAATG -3 ’ ;  Ant i sense , 
5’-AGGGAGCAGCTCTTGGAGAAG-3’. To facilitate 
comparisons between sample groups, quantities of all targets in 
test samples were normalized to GAPDH. PCR products were 
run on 1.5% agarose gels, stained with ethidium bromide and 
photographed [12].
Statistical Analysis
All the values were expressed as mean ± standard error of mean. 
The results were analyzed statistically using one-way ANOVA 
followed by Tukey’s multiple comparison test using GraphPad 
Prism version 4.0 for Windows, GraphPad Software, San Diego 
California USA. The minimum level of significance was fixed 
at P < 0.05.
RESULTS
Extraction of Plant Material
The leaf powder of G. sylvestre was successively extracted with 
dichloromethane, hexane, ethyl acetate, and methanol. The 
extractive values of dichloromethane, hexane, ethylacetate, and 
methanol were found to be 0.52, 0.7, 2.5, and 3.3% w/w (gram 
per gram), respectively. In a pilot study, all the extracts were 
subjected for glucose uptake assay using L6 myotube and based 
on the findings methanolic extract was found to be promising; 
hence, only methanolic extract was subjected for further studies.
Evaluation of Glucose Uptake
Glucose uptake activity of MLGS was assessed using 
rosiglitazone (50 μg/ml) as the reference standard, and the dose 
of rosiglitazone was selected based on the pilot plant study 
performed in house (unpublished data).
The MLGS at concentrations ranging from 250 to 750  μg/ml 
showed dose-dependent stimulation of glucose uptake. Noteworthy, 
MLGS at 750 μg/ml concentration has offered approximately 
2-fold increase in glucose uptake from basal glucose concentration, 
similarly, rosiglitazone also showed a substantial increase in glucose 
uptake. The results are given in Figure 1.
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Further, the outcome of MLGS on glucose uptake was thought 
to be intervened through increased expression of GLUT-4 and 
PPAR-γ synthesis and thereby enhanced protein synthesis. 
To authenticate this hypothesis, another experiment was 
carried out connected to the glucose uptake activity of MLGS, 
in presence and absence of a protein synthesis inhibitor 
cycloheximide (CHX) in L6 myotubes. The findings have 
revealed complete blockade of glucose uptake activity of MLGS 
in the presence of CHX; these findings propose that the elevated 
glucose uptake activity of MLGS is due to enhanced protein 
synthesis [Figure 2].
Effect of MLGS on GLUT-4, PPAR-γ, Adiponectin, and 
Leptin Transcription Level
We determined the outcome of MLGS on GLUT-4, PPAR-γ, 
adiponectin, and leptin mRNA expression by semi-quantitative 
RT-PCR. MLGS has significantly elevated the GLUT-4 transcript 
level compared to control. A depictive image of agarose gel 
[Figure 3a and b] and The corresponding densitometry scanning 
[Figure 3c] confirms approximately 7.1-fold increase in GLUT-4 
expression in MLGS (750 μg/ml)  group and 4.6-fold increase in 
rosiglitazone group compared to control [Figures 3a-c].
As a second step, we studied the role of PPAR-γ in GLUT 
activity exhibited by MLGS. In findings, the MLGS  has 
shown significant and dose-dependent upregulation of 
PPAR-γ compared to control, the higher dose of MLGS (750 
μg/ml) showed approximately ~ 2.5-fold increase in PPAR-γ 
expression compared to control, similarly, the reference standard 
rosiglitazone has also shown a significant increase in PPAR-γ 
compared to control. The results are shown in Figure 4a-c.
Figure 1: Glucose uptake activity of methanolic leaf extract of 
Gymnema sylvestre (MLGS) in L6 myotubes. All of the values are 
expressed as x ± standard error of mean (n = 3); means of various 
groups were statistically compared by ANOVA followed by Tukey’s 
multiple comparison test using Graph Pad version 4.0. †P < 0.001 
corresponds to rosiglitazone versus control; *P < 0.05, **P < 0.01, 
***P < 0.01 corresponds to MLGS versus control
Figure 2: Effect of cycloheximide on methanolic leaf extract of 
Gymnema sylvestre (MLGS) intervening glucose uptake in L6 
myotubes. ns: Not signifi cant. The values are x¯ ± Standard error of 
mean (n = 3) of independent experiments, means of various groups 
were statistically compared by ANOVA followed by Tukey’s multiple 
comparison test using Graph Pad version 4.0. †P < 0.001 corresponds 
to rosiglitazone versus control; *P < 0.05, **P < 0.01, ***P < 0.01 
corresponds to MLGS versus control. nsP > 0.05 corresponds to MLGS 
500 μg/ml + cycloheximide versus MFMC 500 μg/ml
Figure 3: Effect of the methanolic leaf extract of Gymnema sylvestre 
(MLGS) on glucose transport-4 transcripts in L6 myotubes. (a and 
b) - M: Ikbp marker, Lane 1: 250 μg/ml MLGS, Lane 2: 500 μg/ml MLGS, 
Lane 3: 750 μg/ml MLGS, Lane 4: 50 μg/ml rosiglitazone, Lane 5: Control. 
(c) The values are x ± standard error of mean (n = 3) of independent 
experiments, means of various groups were statistically compared by 
ANOVA followed by Tukey’s multiple comparison test using Graph Pad 
version 4.0. †P < 0.001 corresponds to rosiglitazone versus control; 




Figure 4: Effect of the methanolic leaf extract of Gymnema sylvestre 
(MLGS) on peroxisome proliferator-activated receptor-gamma transcripts 
in L6 myotubes. (a and b) - M: Ikbp marker, Lane 1: 250 μg/ml MLGS, 
Lane 2: 500 μg/ml MLGS, Lane 3: 750 μg/ml MLGS, Lane 4: 50 μg/ml 
rosiglitazone, Lane 5: Control. (c) The values are x ± standard error 
of mean (n = 3) of independent experiments, means of various groups 
were statistically compared by ANOVA followed by Tukey’s multiple 
comparison test using Graph Pad version 4.0.†P < 0.001 corresponds 
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Based on the above findings, it was concluded that MLGS 
could upregulate the expression of GLUT-4 and PPAR-γ, and 
thereby increased the glucose uptake in vitro. Further, the 
glucose uptake activity of MLGS was completely abolished in 
the presence of CHX (1 μg/ml), which is a protein synthesis 
inhibitor, thus it was confirmed that glucose uptake activity of 
MLGS is mediating through enhanced expression of GLUT-4 
and PPAR-γ. Furthermore, in another experimental set, MLGS 
has shown enhanced expression of adiponectin, leptin by 3.9-
fold and 7.1-fold, respectively, compared to control [Figures 5a-c 
and 6a-c ] Collectively, it can be concluded that MLGS shows 
hypoglycemic activity through enhanced expression of GLUT-4, 
and reverses insulin resistance by enhancing the expression of 
PPAR-γ, adiponectin, and leptin, respectively.
DISCUSSION
Diabetes is a metabolic disorder with varied etiology, many 
important biochemical entities involved in the development of 
abnormal GLUT. In this context, the markers such as GLUT-4, 
PPAR-γ, adiponectin, and leptin are well known to play a crucial 
role in insulin-dependent glucose transport [25]. The declined 
GLUT-4 translocation and defective insulin signaling cascade 
were demonstrated as one among the prevalent factors in 
type 2 diabetes and insulin resistance [25]. Thus, the agents 
that enhance the GLUT-4 expression could decrease the 
circulating blood glucose levels by enhancing cellular glucose 
uptake. In this context, L6 muscle cell line is a relevant in vitro 
model to study the GLUT activity; moreover, skeletal muscle 
is the main site for primary glucose clearance and glucose 
utilization [26]. Earlier reports of L6 myotubes manifested 
the maximum glucose uptake activity by troglitazone and 
rosiglitazone at 10 and 100 μM concentrations, respectively 
[10]. In addition, the enhanced glucose uptake in L6 cells is 
majorly intervened through increased GLUT-4 level [26,10]. In 
these lines, the findings in the present study are in compliance 
with the literature reports where there is a coincidental increase 
in glucose uptake along with enhanced GLUT-4 levels in L6 
myotubes, the MLGS has shown increased glucose uptake, 
and facilitated the enhanced GLUT-4 expression. In literature, 
CHX was used as a protein synthesis inhibitor to completely 
abolish the troglitazone-mediated glucose uptake [26]. Similarly, 
in the present study, the glucose uptake activity of MLGS was 
completely blocked in the presence of CHX, which clearly 
confirmed the role of new protein synthesis compatible to 
GLUT.
Altogether, the above findings proved that glucose uptake is 
dependent on increased or decreased expression of GLUT-4, 
further enhanced glucose uptake in the present study was 
concomitant with the increased expression of GLUT-4 encoding 
mRNA, in L6 myotubes on incubation with MLGS [27].
Furthermore, PPAR-γ is a nuclear transcriptional factor known 
for its pivotal role in the insulin receptor signaling cascade in 
glucose uptake, also the levels of PPAR-γ is noted to be less in 
insulin resistance. In this context, the PPAR-γ agonists belong 
to the chemical class of thiazolidinedione’s (TDZs) (such as 
rosiglitazone and pioglitazone) play a major role in reversing 
the insulin resistance [28]. Further, PPAR-γ activation leads to 
enhanced glucose-stimulated insulin secretion and increased 
insulin sensitivity [29].
In continuation, adiponectin is an abundantly expressed 
adipokine that exerts a potent insulin-sensitizing effect through 
binding to its receptors AdipoR1 and AdipoR2, leading to 
activation of AMPK, PPAR-α, and presumably other yet-unknown 
signaling pathways. Thus, the serum levels of adiponectin have a 
positive correlation with insulin sensitivity [30]. Adiponectin is 
known to increase insulin sensitivity by three major mechanisms, 
First, in skeletal muscle adiponectin increases the expression 
of CD36 and acyl-coenzyme-A oxidase molecules involved in 
transport and combustion of FA, and also increases uncoupling 
protein 2 required during energy dissipation. These changes 
led to decreased triglyceride content in skeletal muscle, which 
contributes to improved insulin signaling transduction [17]. 
Furthermore, adiponectin stimulates phosphorylation of acetyl 
coenzyme-A carboxylase, increases fatty-acid combustion, 
Figure 6: Effect of the methanolic leaf extract of Gymnema sylvestre 
(MLGS) on leptin transcripts in 3T3 L1 cell lines. (a and b) M: Ikbp 
marker, Lane 1: Control, Lane 2: 50 μg/ml rosiglitazone, Lane 
3: 250 μg/ml MLGS, Lane 4: 500 μg/ml MLGS, Lane 5: 750 μg/ml MLGS, 
(c) The values are x ± standard error of mean (n = 3) of independent 
experiments, means of various groups were statistically compared by 
ANOVA followed by Tukey’s multiple comparison test using Graph Pad 
version 4.0.†P < 0.001 corresponds to rosiglitazone versus control; 




Figure 5: Effect of the methanolic leaf extract of Gymnema sylvestre 
(MLGS) on Adiponectin transcripts in 3T3 L1 cell lines. (a and b) - M: 
Ikbp marker, Lane 1: Control, Lane 2: 50 μg/ml rosiglitazone, Lane 
3: 250 μg/ml MLGS, Lane 4: 500 μg/ml MLGS, Lane 5: 750 μg/ml MLGS, 
(c) The values are x ± standard error of mean (n = 3) of independent 
experiments, means of various groups were statistically compared by 
ANOVA followed by Tukey’s multiple comparison test using Graph Pad 
version 4.0. †P < 0.001 corresponds to rosiglitazone versus control; 
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glucose uptake, and lactate production in myocytes, through 
activation of AMPK. These changes reduce gluconeogenesis 
in the liver; thus, adiponectin shows acute glucose lowering 
effect [17]. Remarkably, the PPAR-γ agonist belongs to TZDs 
class are well known to raise the circulating adiponectin levels, 
this is well demonstrated by exposing 3T3-L1 cells to TZDs [31].
In line with the above reports, in the present study, the 
effect of MLGS on adiponectin levels was evaluated using 
3T3-L1 cell lines, and the outcomes of the study showed a 
significant increase in expression of adiponectin in MLGS and 
rosiglitazone-treated groups.
In obesity-linked insulin resistance, both adiponectin and 
adiponectin receptors are downregulated. Apart from adiponectin, 
Leptin is another very important adipocytokine majorly secreted 
by adipocytes, the net action of leptin is to inhibit appetite, 
stimulate thermogenesis, decrease blood glucose, and reduce body 
weight and fat. Leptin also directly affects glucose metabolism 
in the liver, by inhibiting gluconeogenesis mediated through 
phosphatidylinositol 3-kinase (PI3K)-dependent activation of 
phosphodiesterase 3B [32], interferes with lipid metabolism 
mediated through activation of PI3K [33]. Further, many studies 
have confirmed a complex interaction between leptin and insulin-
signaling pathways on glucose metabolism. The observations from 
in vitro and in vivo studies suggest that leptin promotes energy 
dissipation and decreases lipid deposition in adipose tissues [33].
Leptin receptor-mediated JAK–STAT signaling is essential for 
regulation of food intake and body weight. It also limits the 
accumulation of triglycerides in the liver and skeletal muscle 
through a combination of direct activation of AMPK and 
indirect actions mediated through central neural pathways, 
thereby improving insulin sensitivity [34]. In addition, leptin 
regulates pancreatic β-cells function through direct actions [35] 
and indirectly through central neural pathways [36].
On the whole, leptin enhances peripheral (hepatic and skeletal 
muscle) insulin sensitivity and modulates pancreatic β cell 
function. Leptin resistance/deficiency leads to reduced leptin-
mediated JAK–STAT signaling and upregulation of suppressor 
of cytokine signaling-3 (SOC-3). In contrary, expression of 
leptin is directly related to insulin sensitization and activation 
of JAK-STAT signaling thereby reducing SOC-3. Altogether, 
expression of leptin has profound positive relation with the 
glucose metabolism and insulin signaling.
In this regard, in the present study, the effect of MLGS was 
examined on the expression of leptin in 3T3-L1 cells in vitro 
using rosiglitazone as the reference standard. A significant 
increase in leptin levels was observed in MLGS and rosiglitazone-
treated groups. These findings observed are in constituent with 
the GLUT-4, PPAR-γ, adiponectin and leptin gene expressions to 
link with the hypoglycemic and antidiabetic activity of MLGS.
CONCLUSION
The role of GLUT-4, PPAR-γ, adiponectin, and leptin in 
insulin dependent glucose transport and insulin resistance is 
well understood with available scientific literature, and thus, 
these factors have a key role in etiology of diabetes and related 
complications.
In the present study, an attempt was made to investigate the 
mechanism involved in hypoglycemic and antidiabetic activity 
of methanolic leaf extract of G. sylvestre.
The findings of the study showed that MLGS could dose-
dependently enhance the expression of GLUT-4, PPAR-γ, 
adiponectin, and leptin, and thereby shows potential antidiabetic 
activity. Interestingly, the actives responsible for hypoglycemic and 
antidiabetic activity of MLGS needs to be isolated, in this regard, 
further studies are in the pipeline to identify and isolate the 
phytoconstituent responsible for antidiabetic activity of MLGS.
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